SYRE
Spyre Therapeutics, Inc.Healthcare$47.58
▲ Bullish
Mkt Cap: $3.74B|Float: 64.4M|SI: 15.5%|DTC: 12.1
Data as of market close Apr 2, 2026
IV Rank
0
IV Pctl
0%
HV 20d
71.5%
52W Range
$11-$51
ATR(14)
$3.06
Exp. Move
±23.0%
P/C Ratio
0.10
Earnings
May 7
GEX Positive
DEX Long
Net Call Premium
IV Low
Max Pain Below
Exp. Move Wide
Low Put/Call
SYRE Key Options Data
- IV Rank
- 0%
- Total GEX
- $0.00B
- Total DEX
- $0.2M
- Max Pain
- $40.00
- Expected Move
- ±23.0%
- Put/Call OI
- 0.10
- Net Premium
- $0.1M
- Spot Price
- $47.58
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$10.95 | ±23.0% | $36.63 | $58.53 |
| 2026-05-15 | 43 | ±$7.45 | ±15.7% | $40.13 | $55.03 |
| 2026-06-18 | 77 | ±$8.45 | ±17.8% | $39.13 | $56.03 |
| 2026-09-18 | 169 | ±$11.00 | ±23.1% | $36.58 | $58.58 |
Explore SYRE options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.